Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM)
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Gestational diabetes mellitus during pregnancy has severe implications for the health of the mother and the fetus. Therefore, early prediction and an understanding of the physiology are an important part of prenatal care. Metabolite profiling is a long established method for the analysis and prediction of metabolic diseases. Here, we applied untargeted and targeted metabolomic protocols to analyze plasma and urine samples of pregnant women with and without GDM. Univariate and multivariate statistical analyses of metabolomic profiles revealed markers such as 2-hydroxybutanoic acid (AHBA), 3-hydroxybutanoic acid (BHBA), amino acids valine and alanine, the glucose-alanine-cycle, but also plant-derived compounds like sitosterin as different between control and GDM patients. PLS-DA and VIP analysis revealed tryptophan as a strong variable separating control and GDM. As tryptophan is biotransformed to serotonin we hypothesized whether serotonin metabolism might also be altered in GDM. To test this hypothesis we applied a method for the analysis of serotonin, metabolic intermediates and dopamine in urine by stable isotope dilution direct infusion electrospray ionization mass spectrometry (SID-MS). Indeed, serotonin and related metabolites differ significantly between control and GDM patients confirming the involvement of serotonin metabolism in GDM. Clustered correlation coefficient visualization of metabolite correlation networks revealed the different metabolic signatures between control and GDM patients. Eventually, the combination of selected blood plasma and urine sample metabolites improved the AUC prediction accuracy to 0.99. The detected GDM candidate biomarkers and the related systemic metabolic signatures are discussed in their pathophysiological context. Further studies with larger cohorts are necessary to underpin these observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 1×
“GDM was diagnosed with a standard 2 h 75 g oral glucose tolerance test (oGTT), according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria (International Association of Pregnancy Study Groups Consensus Panel et al., 2010; Colagiuri et al., 2014).”
MethodSumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294 · cited 1×
“The pooled sample was a mixture of randomly chosen blood aliquots of half of the women, containing most of the metabolites expected in plasma (Dunn et al., 2011).”
MethodEffect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 2×
“, 2011), as well as hyperlipidemia or obesity (Bartha et al., 2008; Clausen et al., 2009; Landon et al., 2009; Gillman et al., 2010; Harreiter et al., 2014) in later life, whereas their children have a higher risk for obesity or impaired fasting glucose (Silverman et al.”
BackgroundSex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Self-citationPrevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective
Zhu, Y., & Zhang, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0699-x · Cited by 1,260 · cited 1×
“The prevalence of GDM is rising worldwide, reaching up to 25.1% (Zhu and Zhang, 2016).”
BackgroundInfluentialSilverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Serotonin regulates pancreatic beta cell mass during pregnancy
Kim, H., Toyofuku, Y., Lynn, F. C., Chak, E., Uchida, T., Mizukami, H., Fujitani, Y., Kawamori, R., Miyatsuka, T., Kosaka, Y., et al. (2010) · Nature Medicine · doi:10.1038/nm.2173 · Cited by 586
Clausen, T. D., Mathiesen, E. R., Hansen, T., Pedersen, O., Jensen, D. M., Lauenborg, J., Schmidt, L., & Damm, P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0305 · Cited by 453
Association of Maternal Diabetes With Autism in Offspring
Xiang, A. H., Wang, X., Martinez, M. P., Walthall, J. C., Curry, E. S., Page, K., Buchanan, T. A., Coleman, K. J., & Getahun, D. (2015) · JAMA · doi:10.1001/jama.2015.2707 · Cited by 395 · cited 1×
“Intrauterine exposure to hyperglycemia is linked to an increased risk for neuropsychiatric and neurodevelopmental disorders of the offspring (Xiang et al., 2015; Nahum Sacks et al., 2016).”
BackgroundEffect of treatment of gestational diabetes mellitus on obesity in the next generation
Gillman, M. W., Oakey, H., Baghurst, P. A., Volkmer, R. E., Robinson, J. S., & Crowther, C. A. (2010) · Diabetes Care · doi:10.2337/dc09-1810 · Cited by 269 · cited 2×
“, 2011), as well as hyperlipidemia or obesity (Bartha et al., 2008; Clausen et al., 2009; Landon et al., 2009; Gillman et al., 2010; Harreiter et al., 2014) in later life, whereas their children have a higher risk for obesity or impaired fasting glucose (Silverman et al.”
BackgroundEffect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
Simmons, D., Devlieger, R., van Assche, A., Jans, G., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoye, G., Harreiter, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3455 · Cited by 225
Self-citationA longitudinal study of depression and gestational diabetes in pregnancy and the postpartum period
Hinkle, S. N., Buck Louis, G. M., Rawal, S., Zhu, Y., Albert, P. S., & Zhang, C. (2016) · Diabetologia · doi:10.1007/s00125-016-4086-1 · Cited by 185 · cited 2×
“Further, GDM affects the psychological health of the mother and the child: GDM increases a woman’s risk of postpartum depression 4-fold (Hinkle et al., 2016), and postpartum depression is decreased with treatment of GDM (Crowther et al., 2005; Beucher et al., 2010).”
BackgroundNahum Sacks, K., Friger, M., Shoham-Vardi, I., Abokaf, H., Spiegel, E., Sergienko, R., Landau, D., & Sheiner, E. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.030 · Cited by 165 · cited 1×
“Intrauterine exposure to hyperglycemia is linked to an increased risk for neuropsychiatric and neurodevelopmental disorders of the offspring (Xiang et al., 2015; Nahum Sacks et al., 2016).”
BackgroundColagiuri, S., Falavigna, M., Agarwal, M. M., Boulvain, M., Coetzee, E., Hod, M., Meltzer, S. J., Metzger, B., Omori, Y., Rasa, I., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.012 · Cited by 132
Metabolomics of Diabetes in Pregnancy.
McCabe, C. F., & Perng, W. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0890-3 · Cited by 41 · cited 1×
“This workflow reveals the power of metabolomics screening of metabolic diseases, especially in the context of physiological interpretation of identified significant changes in metabolites (McCabe and Perng, 2017).”
Background
Cited by
Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Wilson, J. L., Nägele, T., Linke, M., Demel, F., Fritsch, S. D., Mayr, H. K., Cai, Z., Katholnig, K., Sun, X., Fragner, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.011 · Cited by 97
Self-citationMolecular Biomarkers for Gestational Diabetes Mellitus and Postpartum Diabetes
Lu, W., & Hu, C. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002160 · Cited by 52
“Studies have also identified decreases in metabolites, including ethanolamine, lanthionine, 5-methoxytryptamin, threonine, methionine, methionine sulfoxide, acadesine, carnitine, argininate, and melatonin.([19,54,60,76]) The AUC values for these factors ranged from 0.”
BackgroundInfluentialBiochemical and Molecular Biomarkers: Unraveling Their Role in Gestational Diabetes Mellitus
Karami, M., Mousavi, S. H., Rafiee, M., Heidari, R., & Shahrokhi, S. Z. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00980-8 · Cited by 33
Metabolomics in Gestational Diabetes Mellitus: A Review
XIE, J., LI, L., & XING, H. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.005 · Cited by 26
Metadata
- Authors
- Leitner, M., Fragner, L., Danner, S., Holeschofsky, N., Leitner, K., Tischler, S., Doerfler, H., Bachmann, G., Sun, X., Jaeger, W., Kautzky-Willer, A., & Weckwerth, W.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2017-12-21
- Volume
- 4
- Pages
- 84-84
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W2776236834
- Cited by
- 71
- References
- 18
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.